Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other financing activities (2016 - 2024)

Historic Other financing activities for Mimedx (MDXG) over the last 8 years, with Q1 2024 value amounting to $1.1 million.

  • Mimedx's Other financing activities changed N/A to $1.1 million in Q1 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 221730.77%. This contributed to the annual value of $1.1 million for FY2024, which is 221730.77% up from last year.
  • According to the latest figures from Q1 2024, Mimedx's Other financing activities is $1.1 million.
  • In the past 5 years, Mimedx's Other financing activities ranged from a high of $6.5 million in Q3 2020 and a low of -$52000.0 during Q4 2023
  • Over the past 3 years, Mimedx's median Other financing activities value was $1.0 million (recorded in 2020), while the average stood at $2.1 million.
  • Examining YoY changes over the last 5 years, Mimedx's Other financing activities showed a top increase of 896000.0% in 2020 and a maximum decrease of 99932.77% in 2020.
  • Quarter analysis of 3 years shows Mimedx's Other financing activities stood at $906000.0 in 2020, then tumbled by 105.74% to -$52000.0 in 2023, then surged by 2217.31% to $1.1 million in 2024.
  • Its Other financing activities was $1.1 million in Q1 2024, compared to -$52000.0 in Q4 2023 and $906000.0 in Q4 2020.